Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
about
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityBarriers to a cure for HIV in womenAn update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patientsWhat's new for antiretroviral treatment in women with HIVInfluence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.Sex-based differences in HIV type 1 pathogenesisImportance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populationsSex, age, race and intervention type in clinical studies of HIV cure: a systematic review.Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir.Caring for women living with HIV: gaps in the evidence.Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV.Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.Update on rilpivirine: a new potent non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV replication.Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysis.Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128).Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 t
P2860
Q24628212-24078391-9F1B-41DB-93A1-16279998C522Q26768632-57680505-F159-4AF6-846C-2397394213C5Q26827791-0A7942E5-EB99-416E-BDD9-EA08945A4485Q30391322-1B328EB6-B8D6-4D93-9F0D-5FC612C0518EQ33629439-5D808237-B094-401E-93DB-521775D076F2Q34148475-CE9D6FBF-EA3F-464A-95AD-71CAFBF2FBEEQ34826590-96818078-4D0D-4712-96C7-78704AF87BDEQ34870233-A2D58FBC-3928-4F93-A9D3-1E6CD1742028Q36603434-0813C7AC-C84D-4CDA-B226-24DC81714A4CQ37212049-D56AE818-6365-4C54-B7B3-E6877493B49CQ37410986-C50E1178-1FD9-4BC7-8FE0-B61AF675219DQ37538683-1C4612D3-C31E-4501-9F17-64A0490FF5DEQ38060236-1B9D5B5E-3749-412E-8283-62E71FA57453Q38272654-3BB41104-6F4E-4ADF-A4E9-B09E2FE62819Q38853255-7E11FB12-C81F-48CC-834F-0103B5787DE0Q40048002-808307FB-C39E-451C-9FC1-60C8A1DB67C7Q40860723-8E2D246C-FED6-4FAE-8BD6-AEC86E6F807BQ41124916-44C334A3-3196-411A-B074-9A95E4F634FFQ58254289-6C8846CC-AAE7-492D-A798-58891A4E1926
P2860
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@en
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@nl
type
label
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@en
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@nl
prefLabel
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@en
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@nl
P2093
P2860
P1433
P1476
Effect of gender and race on t ...... se III trials ECHO and THRIVE.
@en
P2093
H Crauwels
S Vanveggel
P2860
P304
P356
10.1111/J.1468-1293.2012.00991.X
P577
2012-03-14T00:00:00Z